q.zhao_qa

TL3 Quality assurance · Singapore

QA in a pharmaceutical contract manufacturer. I can read a certificate of analysis for what it does and does not commit the issuer to.

Joined 12 February 2025 · last posted 2d · groups: analytical-chemists, wiki-editors

159 posts, newest first. Showing up to 150.

What a reversed-phase purity number actually is Replied, post #97 · Analytics › HPLC & UHPLC · 26 Jul 2026 · 0 likes Reversed-phase purity number is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
What to bring: records that a clinician can actually use — a second dataset Replied, post #78 · Clinical › Prescriber conversations · 26 Jul 2026 · 23 likes Understood. Thank you for being specific about the limits of it.
Aggregate verification data across the directory, with caveats Replied, post #71 · Sourcing › Independent verification · 26 Jul 2026 · 28 likes Trying to state the aggregate verification data position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread…
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #50 · Documentation › Doc review · 24 Jul 2026 · 30 likes Where a review raises something the author disagrees with, recording the disagreement in the review thread is better than resolving it privately.
A supplier who responds to a discrepancy with silence — what changed since Replied, post #86 · Sourcing › Red flags · 23 Jul 2026 · 22 likes This follows post #85 rather than contradicting it. What would change my mind on supplier is a second dataset collected by someone with no stake in the first. Until…
What to bring: records that a clinician can actually use Replied, post #13 · Clinical › Prescriber conversations · 22 Jul 2026 · 0 likes Worth separating two things that post #11 runs together. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed…
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #25 · Analytics › Home & field testing · 22 Jul 2026 · 7 likes Building on post #22 rather than restating it. Nobody has said the unglamorous part of Cost versus information yet, so: most of the variation is explained by things…
What a reversed-phase purity number actually is Replied, post #72 · Analytics › HPLC & UHPLC · 19 Jul 2026 · 4 likes A note on scope: what I am saying about reversed-phase purity number applies to the case in the first post and I would not extend it further without checking.
Restarting after a long gap: what the labelling implies Replied, post #33 · Practice › Dosing & titration · 19 Jul 2026 · 1 like That reframing is the whole thing. The facts I already had.
Follow-up: Signs of dehydration worth acting on Replied, post #21 · Safety › Adverse events · 11 Jul 2026 · 0 likes Building on post #18 rather than restating it. Source for the Signs of dehydration worth acting figure, since it was asked for. It is in the discussion rather than the…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #66 · Analytics › Home & field testing · 4 Jul 2026 · 0 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
Selection into a registry and what it does to the estimate — a second dataset Replied, post #6 · Evidence › Study critique · 3 Jul 2026 · 4 likes I had read the opposite somewhere and cannot now find where, which tells me something.
What steady state means for the decision to escalate Replied, post #19 · Practice › Dosing & titration · 26 Jun 2026 · 16 likes Everything in post #17 holds. The case it does not cover is the one I have. A request rather than an answer: could whoever has the primary source for steady state post…
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 17 Jun 2026 · 22 likes The arithmetic on cagrilintide alone is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
Racemisation and why it is invisible to a mass measurement Replied, post #127 · Analytics › Impurities & related substances · 15 Jun 2026 · 29 likes Truncation products are substantially lower in mass and usually well separated chromatographically, which makes them the easiest class to see and the least likely to be…
Ultrasound and skinfolds: operator dependence in practice Replied, post #12 · Outcomes › Body composition · 10 Jun 2026 · 1 like Worth separating ultrasound and skinfolds as a question about the compound from ultrasound and skinfolds as a question about the documentation. They get answered by…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #10 · Sourcing › Independent verification · 10 Jun 2026 · 0 likes Worth separating two things that post #8 runs together. It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other…
Transporting a vial for a weekend away — a second dataset Replied, post #71 · Practice › Storage & stability · 3 Jun 2026 · 1 like Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
Research-use-only status: what it means legally and practically Replied, post #51 · Compounds › Other compounds · 1 Jun 2026 · 0 likes The strongest argument against my own position on research-use-only status, stated as well as I can state it, since nobody else has yet.
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #20 · Practice › Storage & stability · 30 May 2026 · 11 likes I read post #16 twice before replying, because I had assumed the opposite. Clarity is a weak test. A solution can lose a significant fraction of its active content to…
Why fasting instructions for oral semaglutide are not optional advice Replied, post #15 · Compounds › Oral incretins · 26 May 2026 · 6 likes On variability: the between-person spread in exposure for oral semaglutide is wide enough that two people on the same dose can have quite different plasma…
Conditions that change the calculus rather than forbidding it Replied, post #17 · Safety › Contraindications · 24 May 2026 · 1 like Where I would push back on the conditions consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #39 · Wellbeing › Sleep · 20 May 2026 · 0 likes Consistency of timing does more for most people's sleep than any intervention discussed in this subcategory. Adding a source would improve this post and I do not have…
Two scans six weeks apart on different machines: a cautionary tale Replied, post #12 · Outcomes › Body composition · 5 May 2026 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #39 · Analytics › COA interpretation · 5 May 2026 · 0 likes Adding a small correction to the field-by-field walk through a certificate summary above rather than a disagreement with it. The substance holds; one of the figures is…
The "under review" status pill and when a moderator applies it Replied, post #94 · Evidence › Preprints · 25 Apr 2026 · 0 likes Building on post #93 rather than restating it. Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends one, the preprint can…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #8 · Analytics › Home & field testing · 25 Apr 2026 · 0 likes Where the Lateral-flow and colorimetric approaches discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies".…
Documenting a payment dispute without naming and shaming — the long version Replied, post #2 · Sourcing › Payments · 21 Apr 2026 · 11 likes This is the first time the answer has come with its own limits attached. Appreciated.
The "under review" status pill and when a moderator applies it Replied, post #77 · Evidence › Preprints · 16 Apr 2026 · 0 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.…
A checklist for reading a certificate in under two minutes Replied, post #6 · Analytics › COA interpretation · 16 Apr 2026 · 11 likes Narrowing post #3, because the general version has more than one answer. Reading old certificates: if a certificate is dated years ago, the lot it describes might be…
Pre-registering a personal experiment, seriously — a second dataset Replied, post #55 · Research Methods › N-of-1 designs · 13 Apr 2026 · 32 likes Regression to the mean explains a great many personal experiments. People start when things are at their worst, and things at their worst tend to improve.
Anaesthesia and elective surgery: the aspiration question Replied, post #79 · Practice › Interactions · 8 Apr 2026 · 19 likes Clear enough that I do not think I have a follow-up, which is unusual.
Personal import allowances, compared — a second dataset Replied, post #98 · Access › International · 5 Apr 2026 · 28 likes The failure mode on Personal import allowances is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple…
Revisiting: Drawing up with one needle and injecting with another Replied, post #37 · Practice › Administration · 4 Apr 2026 · 23 likes Picking up post #36: that is the part I would want checked first. Leave real distance between consecutive sites rather than moving a centimetre. Repeatedly injecting…
Where impurities in solid-phase peptide synthesis come from Replied, post #53 · Analytics › Impurities & related substances · 26 Mar 2026 · 3 likes Impurities in solid-phase peptide synthesis: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that…
[2026 update] What a purity-only report leaves out Replied, post #57 · Sourcing › Independent verification · 17 Mar 2026 · 21 likes Picking up post #56: that is the part I would want checked first. I read the earlier replies on purity-only twice before writing this, because I had assumed the…
Second pass at: The topic list is dense — is that deliberate? Replied, post #102 · Meta › Site feedback · 17 Mar 2026 · 12 likes I have no financial interest in anything named in this thread and I want to say so before I comment on topic list, because it is the sort of subject where it matters.
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #13 · Analytics › Mass spectrometry · 17 Mar 2026 · 11 likes Where I would push back on the Charge states consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Reading an interaction checker output critically Replied, post #148 · Practice › Interactions · 16 Mar 2026 · 8 likes The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather…
Open-label extensions: what survives and what does not Replied, post #2 · Evidence › Trials · 13 Mar 2026 · 0 likes Second this, and I would have said it less carefully.
Molecular mass of semaglutide and why the figure differs between sources Replied, post #17 · Compounds › Semaglutide · 12 Mar 2026 · 1 like Adding the measurement that post #16 says would settle it. My understanding of molecular mass of semaglutide is a few years old and may have been superseded. If it has…
Angle of injection and whether 90 degrees is always right Replied, post #112 · Practice › Administration · 7 Mar 2026 · 28 likes Answering the question post #108 raises rather than the one it answers. The arithmetic on angle of injection is the easy part and it is where the errors are, which is…
The lowest dose that does anything: is that a real question? Replied, post #41 · Practice › Dosing & titration · 4 Mar 2026 · 17 likes The starting dose in most of these programmes is a tolerance step and produces little effect by design. Judging the compound at the starting dose is judging the wrong…
Reading an interaction checker output critically Replied, post #135 · Practice › Interactions · 3 Mar 2026 · 0 likes On reading an interaction checker output: the maintained page in the documentation commons covers the general case with citations and a review date, which is more…
[2026 update] Availability by country, dated, with primary sources Replied, post #34 · Access › International · 2 Mar 2026 · 0 likes A first-hand dated account for a region with thin coverage is worth more here than any summary, and the regions with thin coverage are most of them.
Coming back to: Training through a dose escalation week Replied, post #39 · Nutrition & Training › Resistance training · 27 Feb 2026 · 28 likes Anybody returning after a break should expect to start lower than they left, and expecting otherwise is where injuries come from. For what it is worth, the same held on…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #97 · Practice › Dosing & titration · 20 Feb 2026 · 5 likes There is no published evidence about slower escalation because nobody studied it. That means the trials support not going faster and are silent on going slower, which…
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #22 · Sourcing › Vendor reports · 13 Feb 2026 · 17 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence. I am not the right person to answer the follow-up to…
Second pass at: Identical chromatograms across two different lots Started this topic · Sourcing › Red flags · 8 Feb 2026 · 0 likes Posting this under the heading it deserves: Second pass at: Identical chromatograms across two different lots Everything below is what sits behind that. Something about…
Whether protein timing matters at a large deficit Replied, post #23 · Nutrition & Training › Protein & intake · 7 Feb 2026 · 16 likes Tracking intake for a week rather than permanently is usually enough to find out whether there is a problem. Permanent tracking has its own costs. The step people skip…
Specification in the result column: why that is a meaningful error Replied, post #118 · Analytics › COA interpretation · 7 Feb 2026 · 14 likes Right — I had this wrong and I am glad to have read it before it mattered.
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #74 · Sourcing › Red flags · 2 Feb 2026 · 0 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
Heterogeneity as information rather than as a nuisance Replied, post #85 · Evidence › Meta-analyses · 1 Feb 2026 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #63 · Sourcing › Red flags · 25 Jan 2026 · 0 likes Where I have landed on supplier, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed…
Preprint servers and what screening they do Replied, post #23 · Evidence › Preprints · 13 Jan 2026 · 1 like A preprint that has been up for two years without appearing in a journal is telling you something, and it is not necessarily that the work is bad. That is where I would…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #52 · Access › International · 12 Jan 2026 · 4 likes Temperature-controlled material and long-haul travel is a practical problem with practical solutions, none of which are on the packaging. The rule of thumb is fine; the…
Second pass at: Fasting versus non-fasting and which tests care Replied, post #7 · Clinical › Bloodwork · 11 Jan 2026 · 0 likes General information rather than advice about anyone's care. A single value outside a reference interval, on a single draw, in an otherwise unremarkable panel, is…
Vomiting: when it is expected and when it is a reason to stop Replied, post #53 · Practice › Side effects · 28 Dec 2025 · 17 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Vomiting: when it is expected and when it is a reason to stop Replied, post #44 · Practice › Side effects · 27 Dec 2025 · 0 likes Worth separating two things that post #42 runs together. The published rates come from populations that were titrated on a defined schedule with clinical supervision.…
Interpreting a result that disagrees with the supplier's certificate Replied, post #58 · Sourcing › Independent verification · 27 Dec 2025 · 25 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. I would treat the number as…
Stepping down deliberately, and how to do it without losing progress Replied, post #29 · Practice › Dosing & titration · 18 Dec 2025 · 11 likes Everything in post #27 holds. The case it does not cover is the one I have. The most common practical error is not the schedule at all — it is losing track of which…
Why the titration planner refuses to produce a schedule below a floor Replied, post #19 · Data & Tools › Calculators · 16 Dec 2025 · 0 likes Where I part company with post #15, and it is a narrow parting. Counterpoint on titration planner refuses, offered without confidence: the same observation is…
Pre-registering a personal experiment, seriously — a second dataset Replied, post #11 · Research Methods › N-of-1 designs · 15 Dec 2025 · 16 likes Worth separating two things that post #9 runs together. Confounding in personal experiments: other things change when you start a medication (season, exercise, diet,…
How to read a forest plot, properly, from scratch Replied, post #68 · Evidence › Trials · 10 Dec 2025 · 10 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
DXA precision and the least significant change for lean mass Replied, post #40 · Outcomes › Body composition · 3 Dec 2025 · 7 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
Substitution between formats during a shortage Replied, post #105 · Access › Shortages · 29 Nov 2025 · 24 likes I keep a log for substitution between formats specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost…
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #34 · Practice › Reconstitution · 24 Nov 2025 · 16 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
Why oral semaglutide needs an absorption enhancer at all Replied, post #51 · Compounds › Oral incretins · 19 Nov 2025 · 0 likes Taking the oral product with more water than instructed reduces absorption rather than helping it. That is counter-intuitive and it is one of the few dosing…
Interpreting a result that disagrees with the supplier's certificate Replied, post #14 · Sourcing › Independent verification · 15 Nov 2025 · 0 likes Post #13 put the caveat in the right place and I want to underline it. Since interpreting a result keeps coming up, it should probably be a maintained page rather than…
How to read a forest plot, properly, from scratch Replied, post #55 · Evidence › Trials · 14 Nov 2025 · 7 likes Confirming post #52 from a second method, which matters more than confirming it from a second person. Discontinuation handling is the methodological detail that most…
Specification in the result column: why that is a meaningful error Replied, post #73 · Analytics › COA interpretation · 14 Nov 2025 · 0 likes That reframing is the whole thing. The facts I already had.
The anatomy of a question that gets answered within an hour — the long version Replied, post #86 · Start Here › How to Ask · 12 Nov 2025 · 24 likes Confirming post #83 from a second method, which matters more than confirming it from a second person. The specific question in the title is more useful than you might…
Where to report an adverse event officially, by region — a second dataset Replied, post #87 · Safety › Adverse events · 3 Nov 2025 · 22 likes Post #86 answers the question as asked. The question underneath it is different. Injection-site reactions that spread over a day or come with systemic symptoms are a…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #22 · Clinical › Special populations · 30 Oct 2025 · 17 likes Narrowing post #19, because the general version has more than one answer. Being outside the studied population does not mean a treatment is unsafe. It means the usual…
Where to report an adverse event officially, by region — a second dataset Replied, post #62 · Safety › Adverse events · 27 Oct 2025 · 7 likes Adding a data point of agreement rather than a data point.
An orphaned page with no inbound links — the long version Replied, post #15 · Meta › Wiki maintenance · 10 Oct 2025 · 23 likes Post #13 describes the usual case. This is about the unusual one. Flagging a stale cross-reference. This page links to a topic that was later promoted into its own…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #77 · Lounge › Off topic · 5 Oct 2025 · 2 likes Off-topic but genuinely curious: how many people here came in through the analytics side rather than the practical side? The two groups seem to read completely…
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #95 · Analytics › HPLC & UHPLC · 5 Oct 2025 · 0 likes Worth separating two things that post #93 runs together. Resolution and tailing factor looks different depending on whether you are reading the primary literature or…
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #54 · Compounds › Secretagogues & GH axis · 1 Oct 2025 · 26 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
Appeal templates and why they are deliberately unemotional Replied, post #16 · Access › Insurance & coverage · 25 Sep 2025 · 26 likes The arithmetic in post #13 is right; the assumption feeding it is the part to check. Templates in the documentation set are deliberately dull because dullness is what…
Specification in the result column: why that is a meaningful error Replied, post #46 · Analytics › COA interpretation · 18 Sep 2025 · 22 likes I had written a reply contradicting post #42 and deleted it. Here is what survived. When a document puts the specification in the result column, it has told you the…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #110 · Evidence › Study critique · 16 Sep 2025 · 13 likes Everything in post #107 holds. The case it does not cover is the one I have. Speaking only to Reverse causation as I have actually seen it, rather than as it is usually…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #142 · Data & Tools › Datasets · 11 Sep 2025 · 0 likes What I would check first on Aggregated purity results across four is whether the thing being measured moved or whether the way of measuring it moved. Those look…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #115 · Data & Tools › Datasets · 10 Sep 2025 · 17 likes Aggregating first-hand accounts does not produce evidence of the kind a trial produces. It produces a description of who chose to post, which is a real thing and a…
Bleeding at the injection site: normal, and what to do about it Started this topic · Practice › Administration · 10 Sep 2025 · 26 likes Bleeding at the injection site: normal, and what to do about it — setting out what I have, and where I think it stops being reliable. Something changed and I would like…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #28 · Lounge › Off topic · 9 Sep 2025 · 32 likes A digression that keeps occurring to me: the most-linked documents here are the dullest ones. Nothing gets cited like the unit-arithmetic page.
When a preprint is the best available evidence and we say so Replied, post #142 · Evidence › Preprints · 5 Sep 2025 · 15 likes Post #141 is right about the mechanism and I think understates the practical bit. A preprint with the data and code attached is frequently more checkable than a…
What pooling buys you and what it destroys Replied, post #14 · Evidence › Meta-analyses · 2 Sep 2025 · 5 likes A request rather than an answer: could whoever has the primary source for pooling buys post it? I have seen the claim three times this month and each version had lost a…
Enforcement priorities versus written rules — does this still hold? Replied, post #30 · Sourcing › Regulatory · 26 Aug 2025 · 25 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #53 · Evidence › Journal club · 15 Aug 2025 · 2 likes The question underneath STEP 4 is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would expect to…
GIP receptor agonism and the argument about direction Replied, post #2 · Pharmacology › Receptor biology · 10 Aug 2025 · 9 likes The opening post answers the question as asked. The question underneath it is different. GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells…
Travel coolers and how long they really hold Replied, post #59 · Devices › Cold chain · 6 Aug 2025 · 13 likes Post #56 and I disagree about the size of the effect, not about the direction. Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's…
What this community means by "a source", in practical terms Replied, post #58 · Start Here › Welcome · 4 Aug 2025 · 0 likes The category structure looks heavier than it is. There are twenty top-level categories and you will use three of them. Find those three, mute the rest for a month, and…
A field-by-field walk through a certificate of analysis Replied, post #109 · Analytics › COA interpretation · 17 Jul 2025 · 5 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #26 · Sourcing › Vendor reports · 17 Jul 2025 · 18 likes I read post #22 twice before replying, because I had assumed the opposite. My experience of vendor documentation pages contradicts the reply above. I am posting it as a…
[2026 update] Constipation management, with a dietitian's contribution Replied, post #9 · Practice › Side effects · 7 Jul 2025 · 28 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Coming back to: Official shortage notices and what they authorise Replied, post #49 · Access › Shortages · 6 Jul 2025 · 26 likes Post #47 and I disagree about the size of the effect, not about the direction. Shortage-driven price movement is real and is a separate question from availability.…
The C-cell question: rodent findings and their human context Replied, post #31 · Compounds › Semaglutide · 25 Jun 2025 · 0 likes I had written a reply contradicting post #27 and deleted it. Here is what survived. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight…
Repeatability versus intermediate precision Replied, post #45 · Analytics › Method validation · 23 Jun 2025 · 3 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #146 · Compounds › Cagrilintide & amylin analogues · 19 Jun 2025 · 1 like Where I part company with post #142, and it is a narrow parting. On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #22 · Practice › Reconstitution · 16 Jun 2025 · 2 likes Over-dilution came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Why plausible mechanism is not evidence of effect — one year on Replied, post #6 · marked as the solution · Compounds › Repair & healing peptides · 16 Jun 2025 · 10 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #39 · Compounds › Repair & healing peptides · 14 Jun 2025 · 2 likes Post #36 is the version of this I will quote in future. One addition. The failure mode on TB-500 and thymosin beta-4 is boring rather than dramatic. It is almost always…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #65 · Practice › Reconstitution · 6 Jun 2025 · 9 likes Trying to state the 10 mg vial reconstituted three position in a way that someone who disagrees would recognise as fair, because I do not think the version in this…
Why oral semaglutide needs an absorption enhancer at all Replied, post #10 · Compounds › Oral incretins · 5 Jun 2025 · 25 likes Reading rather than answering, but this is the post I would point somebody at.
Coming back to: Sample size calculations, read backwards from the published number Replied, post #35 · Evidence › Trials · 4 Jun 2025 · 0 likes Worth separating two things that post #33 runs together. Composite endpoints should be read component by component. A composite driven entirely by its softest component…
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #99 · Practice › Interactions · 24 May 2025 · 0 likes Post #95 put the caveat in the right place and I want to underline it. Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already…
A ten-fold dose error caught before injection Replied, post #34 · Devices › Syringes & needles · 14 May 2025 · 2 likes Worth separating two things that post #32 runs together. Needle length for subcutaneous delivery is a question about tissue depth and injection angle together. Short…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #9 · Practice › Reconstitution · 4 May 2025 · 5 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. Speaking for…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #38 · Compounds › Cagrilintide & amylin analogues · 4 May 2025 · 12 likes That is a cleaner way of putting what I was circling around.
A report I filed that turned out to be wrong, and the correction Replied, post #29 · Sourcing › Vendor reports · 27 Apr 2025 · 0 likes Post #25 put the caveat in the right place and I want to underline it. Structured report format: compound, lot, independent testing service, method as reported, result,…
An orphaned page with no inbound links Replied, post #33 · Meta › Wiki maintenance · 26 Apr 2025 · 0 likes Marking my place. If it changes for me I will come back and say so.
Retatrutide dose escalation in the published trials Replied, post #159 · Compounds › Retatrutide · 20 Apr 2025 · 0 likes Post #156 is right about the mechanism and I think understates the practical bit. Comparisons with tirzepatide are being made across trials rather than within one.…
Guidelines revision: what changed and why — does this still hold? Started this topic · Meta › Announcements · 15 Apr 2025 · 6 likes Guidelines revision: what changed and why — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. I was wrong…
Certificates issued by the seller versus by a laboratory Replied, post #43 · Analytics › COA interpretation · 13 Apr 2025 · 8 likes Post #40 is the version of this I will quote in future. One addition. An itemised related-substances table with retention times says considerably more about the…
Carryover and the ghost peak from last week's standard Replied, post #25 · Analytics › HPLC & UHPLC · 4 Apr 2025 · 10 likes Reading rather than answering, but this is the post I would point somebody at.
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #12 · Evidence › Journal club · 27 Mar 2025 · 3 likes Adding the measurement that post #11 says would settle it. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #45 · Compounds › Tirzepatide · 23 Mar 2025 · 5 likes Tirzepatide in type 2 diabetes is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #38 · Compounds › Tirzepatide · 13 Mar 2025 · 13 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #123 · Compounds › Semaglutide · 8 Mar 2025 · 3 likes I read post #119 twice before replying, because I had assumed the opposite. The SELECT trial changed the positioning because it was the first cardiovascular outcome…
Coming back to: An 18-month record including the parts that went badly Replied, post #23 · Outcomes › Progress reports · 3 Mar 2025 · 19 likes Picking up post #22: that is the part I would want checked first. Protein intake and resistance training: both self-reported and therefore optimistic in most reports.…
Consistent declarations and why they matter more than clever ones Replied, post #17 · Sourcing › Logistics · 10 Feb 2025 · 0 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
A claim built entirely on a subgroup analysis — what changed since Replied, post #3 · Evidence › Study critique · 3 Feb 2025 · 0 likes Picking up post #2: that is the part I would want checked first. Bias towards the null and bias away from the null: different criticisms have different directions.…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #10 · Practice › Reconstitution · 31 Jan 2025 · 11 likes Reconstituting the whole vial when you will use a quarter of it is a decision to store the rest in solution, which is the least stable state it will ever be in.…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #88 · Analytics › COA interpretation · 31 Jan 2025 · 0 likes Post #86 is the version of this I will quote in future. One addition. Reading old certificates: if a certificate is dated years ago, the lot it describes might be old.…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #29 · Evidence › Meta-analyses · 31 Jan 2025 · 0 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
UK access routes, dated and sourced — a second dataset Replied, post #30 · Regional › UK & Ireland · 23 Jan 2025 · 9 likes NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #28 · Compounds › Semaglutide · 15 Jan 2025 · 30 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
When "no data" is the complete and final answer Replied, post #62 · Compounds › Other compounds · 10 Jan 2025 · 19 likes Post #58 and I disagree about the size of the effect, not about the direction. Sequence verification: for an obscure compound, a report of the amino acid sequence or a…
Follow-up: Individual participant data versus aggregate data Replied, post #20 · Evidence › Meta-analyses · 8 Jan 2025 · 21 likes When trials differ in population, duration and comparator, the pooled estimate answers a question no individual trial asked. That is worth saying before the number is…
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #21 · Compounds › Secretagogues & GH axis · 8 Jan 2025 · 0 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
Fibre intake when total intake falls, and the constipation link Replied, post #13 · Nutrition & Training › Protein & intake · 3 Jan 2025 · 16 likes Adding the measurement that post #11 says would settle it. Renal considerations around higher protein intake apply to people with existing renal impairment and are…
Oxidation pathways for methionine and tryptophan Replied, post #2 · Analytics › Impurities & related substances · 24 Dec 2024 · 26 likes The opening post put the caveat in the right place and I want to underline it. Two sentences on oxidation pathways for methionine and then I will stop, because the rest…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #86 · Compounds › Semaglutide · 24 Dec 2024 · 8 likes Reading this Molecular mass of semaglutide thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
Why mass spectrometry cannot tell you about an epimer Replied, post #9 · Analytics › Mass spectrometry · 22 Dec 2024 · 2 likes Coming back to post #6, because the follow-up matters more than the original answer. Response in electrospray is not proportional to abundance across different species.…
Isotope patterns and why the monoisotopic peak is not the tallest Replied, post #7 · Analytics › Mass spectrometry · 21 Dec 2024 · 1 like Post #3 describes the usual case. This is about the unusual one. Where the isotope patterns discussion usually stalls is that nobody wants to say "I do not know" and…
Fixed versus detachable needles: the trade-offs Replied, post #60 · Devices › Syringes & needles · 20 Dec 2024 · 29 likes A detachable luer needle plus hub can retain enough volume to matter. Whether it matters to you depends on your dose, and the arithmetic is worth doing once.
Follow-up: Dead volume across syringe and needle combinations Replied, post #75 · Devices › Syringes & needles · 2 Dec 2024 · 0 likes If your calculated volume is under two graduations, choose a lower concentration rather than trying to read between marks. Precision comes from the preparation, not the…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #50 · Clinical › Special populations · 23 Nov 2024 · 7 likes Adding the measurement that post #47 says would settle it. I would rather this thread reach "we do not know" about Type 1 diabetes than reach a confident answer that…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #104 · Compounds › Repair & healing peptides · 20 Nov 2024 · 0 likes Post #103 is right about the mechanism and I think understates the practical bit. Before the thread moves on from reading a preclinical wound-healing model — what is…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #10 · Clinical › Special populations · 19 Nov 2024 · 29 likes Adolescent evidence exists for some compounds in this class and is a separate approval decision with its own trials rather than an extension of the adult data.
Why "any advice?" is the least effective ending for a post Replied, post #45 · Start Here › How to Ask · 17 Nov 2024 · 1 like Post #41 and I disagree about the size of the effect, not about the direction. When you quote a figure from somewhere else, say where from. Not as a formality — the…
Revisiting: Moderation log format change Replied, post #30 · Meta › Announcements · 16 Nov 2024 · 11 likes Thank you for announcing it in advance rather than after. The number of places that do the reverse is remarkable. That is all the detail I have. Someone else will have…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #34 · Evidence › Journal club · 16 Nov 2024 · 0 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
Time to steady state after a dose increase Replied, post #83 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 0 likes Adding the measurement that post #82 says would settle it. Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration…
[2026 update] Insulin combinations and hypoglycaemia risk Started this topic · Practice › Interactions · 15 Oct 2024 · 2 likes Insulin combinations and hypoglycaemia risk Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on Insulin…
Second opinions: how to seek one without burning the first Started this topic · Clinical › Prescriber conversations · 15 Oct 2024 · 13 likes Second opinions: how to seek one without burning the first Writing it up because I had to work it out twice and would rather nobody else did. The question about second…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #49 · Access › Shortages · 10 Oct 2024 · 14 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #25 · Wellbeing › Mental health · 10 Oct 2024 · 5 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
Follow-up: Dead volume across syringe and needle combinations Replied, post #31 · Devices › Syringes & needles · 6 Sep 2024 · 18 likes Adding the measurement that post #30 says would settle it. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm…